scholarly journals SCD-HEFT: NON-SUSTAINED VENTRICULAR TACHYCARDIA ON BASELINE HOLTER MONITOR ASSOCIATION WITH APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY FOR VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION

2011 ◽  
Vol 57 (14) ◽  
pp. E151 ◽  
Author(s):  
Hans Joseph Moore ◽  
Ross D. Fletcher ◽  
Mason D. Platt ◽  
Robin Boineau ◽  
Jill Anderson ◽  
...  
2014 ◽  
Vol 41 (3) ◽  
pp. 329-331 ◽  
Author(s):  
Fayaz Ahmad Hakim ◽  
Anil Pandit ◽  
Farouk Mookadam ◽  
Sylvia Mamby

Benign cardiac fibroma is rarely reported in adults. Its clinical symptoms are related to outflow obstruction or dysrhythmias. We present the case of a 70-year-old woman who had a syncopal episode from ventricular tachycardia caused by cardiac fibroma. Because of unfavorable tumor anatomy, the patient was not a candidate for surgical excision, and she declined orthotopic heart transplantation. To prevent sudden cardiac death, we placed an implantable cardioverter-defibrillator, and the patient remained well throughout the 2-year follow-up period. To our knowledge, this is the first report of implantable cardioverter-defibrillator therapy to treat an adult patient's unresectable cardiac fibroma.


2013 ◽  
Vol 6 ◽  
pp. CCRep.S13380
Author(s):  
Antoine Kossaify

We report on a 70-year-old male patient who was recipient of GEM III DR 7275 Cardioverter Defibrillator, and who presented with inappropriate shocks. The patient had a documented slow ventricular tachycardia (VT), and the device was programmed to detect VT at rates >100 bpm, fast VT (FVT, via VT) at rates >150 bpm, and ventricular fibrillation (VF) at rates >188 bpm. After detection of FVT, efficient therapy was delivered; however, this was immediately followed by multiple inappropriate therapies. Inappropriate therapies were discussed, with a focus on programming features.


Circulation ◽  
2012 ◽  
Vol 125 (7) ◽  
pp. 967-969 ◽  
Author(s):  
Polychronis Dilaveris ◽  
Panagiota Pietri ◽  
Dimitris Tsiachris ◽  
Konstantinos Gatzoulis ◽  
Christodoulos Stefanadis

2021 ◽  
pp. 36-42
Author(s):  
Gerald M Lawrie

The treatment of drug-refractory chronic ventricular tachycardia (VT) has undergone a revolution over the last 50 years. We now have automatic implantable cardioverter defibrillator therapy with pace-terminating capabilities, and catheter ablation of VT has refined mapping and improved methods of lesion generation. Between 1980 and 1993, Houston Methodist Hospital became a leader in the diagnosis and surgical ablation of VT and other arrhythmias. This is a brief account of that period and some of the experiences and lessons that have led to significant advances used today.


Sign in / Sign up

Export Citation Format

Share Document